Where can I buy Aciu shares?
Shares of ACIU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What are analysts'target prices for AC Immune's stock?
3 equities research analysts have issued 12-month target prices for AC Immune's stock. Their predictions range from $8.00 to $18.00. On average, they anticipate AC Immune's share price to reach $14.00 in the next twelve months.
What was the earnings release for acac immune SA (Aciu)?
AC Immune SA (NASDAQ:ACIU) announced its earnings results on Monday, November, 8th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.27) by $0.03.
How much did American Inc (Aciu) raise in its IPO?
(ACIU) raised $55 million in an initial public offering (IPO) on Friday, September 23rd 2016. The company issued 4,600,000 shares at a price of $11.00-$13.00 per share.
Is ACIU a good stock to buy?
AC Immune SA (NASDAQ:ACIU) The 3 analysts offering 12-month price forecasts for AC Immune SA have a median target of 15.01, with a high estimate of 16.17 and a low estimate of 8.35. The median estimate represents a +344.11% increase from the last price of 3.38.
Is AC Immune a buy?
AC Immune has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Should I buy or sell AC Immune stock right now?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AC Immune in the last year. There are currently 2 buy ratings for the stoc...
What is AC Immune's stock price forecast for 2022?
2 brokers have issued 1 year price objectives for AC Immune's stock. Their forecasts range from $15.00 to $16.00. On average, they expect AC Immune...
How has AC Immune's stock price performed in 2022?
AC Immune's stock was trading at $4.95 at the beginning of the year. Since then, ACIU shares have decreased by 31.7% and is now trading at $3.38....
When is AC Immune's next earnings date?
AC Immune is scheduled to release its next quarterly earnings announcement on Wednesday, August 3rd 2022. View our earnings forecast for AC Immune .
How were AC Immune's earnings last quarter?
AC Immune SA (NASDAQ:ACIU) released its quarterly earnings data on Tuesday, March, 22nd. The company reported ($0.28) earnings per share (EPS) for...
Who are AC Immune's key executives?
AC Immune's management team includes the following people: Dr. Andrea Pfeifer Ph.D. , Co-Founder, CEO & Director (Age 65, Pay $1.1M) Mr. Piergio...
What is Andrea Pfeifer's approval rating as AC Immune's CEO?
3 employees have rated AC Immune CEO Andrea Pfeifer on Glassdoor.com . Andrea Pfeifer has an approval rating of 35% among AC Immune's employees. T...
Who are some of AC Immune's key competitors?
Some companies that are related to AC Immune include Myovant Sciences (MYOV) , MannKind (MNKD) , Arcutis Biotherapeutics (ARQT) , Zentalis Phar...
What other stocks do shareholders of AC Immune own?
Based on aggregate information from My MarketBeat watchlists, some companies that other AC Immune investors own include Sorrento Therapeutics (SRN...
About AC Immune
Headlines
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
AC Immune (NASDAQ:ACIU) Frequently Asked Questions
Could The AC Immune SA (NASDAQ:ACIU) Ownership Structure Tell Us Something Useful?
What is AC Immune SA?
2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AC Immune in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" AC Immune stock. View analyst ratings for AC Immune or view top-rated stocks.
Does market cap include convertible securities?
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding.
What is AC Immune SA?
It does not include securities convertible into the common equity securities. "Market Cap" is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable).
How long are futures trading delayed?
AC Immune SA engages in the discovery and development of therapeutic and diagnostic products for neurodegenerative diseases. It leverages proprietary technology platforms to discover, design, and develop novel, proprietary medicines for prevention, diagnosis, and treatment...
Coca-Cola (KO) Stock Rises on Q4 Earnings & Revenue Beat
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
Will Procter & Gamble (PG) Retain Its Upside Story in 2022?
Coca-Cola's (KO) Q4 results reflect gains from recovery across markets and strategic transformation. KO also issues an encouraging 2022 view.
